Bigul

VENUS REMEDIES LTD. - 526953 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Compliance under regulation 39(3) of SEBI (LODR)Regulations, 2015.: Details of lost certificate.
17-04-2019
Bigul

VENUS REMEDIES LTD. - 526953 - Compliance Under Regulation 40(10) Of SEBI (LODR)Regulations, 2015.

Compliance under regulation 40(10) of SEBI (LODR)Regulations, 2015.
17-04-2019
Bigul

Venus Remedies Ltd - 526953 - Statement Of Investor Complaints For The Quarter Ended March 2019

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 011110 Name of the Signatory :- NehaDesignation :- Company Secretary and Compliance Officer
10-04-2019
Bigul

Venus Remedies Ltd - 526953 - Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended On 31.03.2019.

compliance certificate under regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended on 31.03.2019.
10-04-2019
Bigul

Venus Remedies Ltd - 526953 - Shareholding for the Period Ended March 31, 2019

Venus Remedies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click here
08-04-2019
Bigul

VENUS REMEDIES LTD. - 526953 - Announcement Under Regulation 30 Of SEBI (LODR)Regulations, 215 (Intimation Of Amendment In Codes Under The SEBI (Prohibition Of Insider Trading) Regulations, 2015)

Announcement under Regulation 30 of SEBI (LODR)Regulations, 215 (Intimation of amendment in Codes under the SEBI (Prohibition of Insider Trading) Regulations, 2015)
04-04-2019
Bigul

VENUS REMEDIES LTD. - 526953 - Closure of Trading Window

Pursuant to Code of Conduct as per Regulation 9 & clause 4 of Schedule B of SEBI (Prohibition of Insider Trading) Regulations, 2015 and clarification issued by stock exchanges in this regard on 2nd April, 2019, the trading window for dealing in equity shares of the Company shall remain closed with immediate effect till 48 hours after the declaration of financial results for the quarter/year ended on March 31, 2019 for designated persons and their immediate relatives. All concerned are requested to comply the same. Kindly take the same of your records.
04-04-2019
Bigul

VENUS REMEDIES LTD. - 526953 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Pls find enclosed herewith newspaper publication of Unaudited Financial Results for the quarter and nine months ended on 31.12.2018.
16-02-2019
Bigul

Venus Remedies Ltd - 526953 - Unaudited Financial Results For The Quarter Ended On 31.12.2018

Unaudited Financial Results for the quarter ended on 31.12.2018
14-02-2019
Bigul

VENUS REMEDIES LTD. - 526953 - Outcome of Board Meeting

This is to inform you that, the Board of Directors of the Company at its meeting held today inter alia considered and approved Unaudited Financial Results for the quarter ended on 31.12.2018.
14-02-2019
Next Page
Close

Let's Open Free Demat Account